142 related articles for article (PubMed ID: 33957960)
21. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
22. Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia.
Wu W; Liu R; Chen L; Chen H; Zhang S
Medicine (Baltimore); 2016 Feb; 95(8):e2779. PubMed ID: 26937905
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.
Lee KN; Jackson KW; Christiansen VJ; Dolence EK; McKee PA
J Thromb Haemost; 2011 May; 9(5):987-96. PubMed ID: 21251197
[TBL] [Abstract][Full Text] [Related]
24. [Hemorrhagic syndrome and isolated alpha 2-antiplasmin deficiency. Apropos of a case].
Guermazi S; Khelif A; Conrad J; Ennabli S; Dellagi K
Pathol Biol (Paris); 1997 Jun; 45(6):483-6. PubMed ID: 9309264
[TBL] [Abstract][Full Text] [Related]
25. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
26. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
Avvisati G; ten Cate JW; Sturk A; Lamping R; Petti MG; Mandelli F
Br J Haematol; 1988 Sep; 70(1):43-8. PubMed ID: 2460126
[TBL] [Abstract][Full Text] [Related]
27. A novel variant causing α2 antiplasmin deficiency: case report and experience in a UK centre.
Akay M; Zaidi A; Vaidya S; Sivapalaratnam S; Theodoulou A; Platton S; Hart D; Pasi J; Bowles L
Br J Haematol; 2019 Oct; 187(2):e42-e44. PubMed ID: 31441040
[No Abstract] [Full Text] [Related]
28. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
29. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
Meyer K; Williams EC
Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
[TBL] [Abstract][Full Text] [Related]
30. Defective α
Mitchell JL; Wright S; Kazi S; Watson HG; Mutch NJ
Br J Haematol; 2017 Sep; 178(5):794-799. PubMed ID: 28516512
[TBL] [Abstract][Full Text] [Related]
31. [A congenital α2-antiplasmin deficiency].
Igala M; Oukkach B; Khoubila N; Faez S; Benchekroun S
Ann Biol Clin (Paris); 2013; 71(1):93-5. PubMed ID: 23396430
[TBL] [Abstract][Full Text] [Related]
32. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
33. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
Jansen JW; Haverkate F; Koopman J; Nieuwenhuis HK; Kluft C; Boschman TA
Thromb Haemost; 1987 Apr; 57(2):171-5. PubMed ID: 2440124
[TBL] [Abstract][Full Text] [Related]
34. Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.
Morishima Y; Kamisato C; Honda Y
J Thromb Thrombolysis; 2020 Jan; 49(1):94-99. PubMed ID: 31396790
[TBL] [Abstract][Full Text] [Related]
35. Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin.
Robbie LA; Bennett B; Keyt BA; Booth NA
Br J Haematol; 2000 Nov; 111(2):517-23. PubMed ID: 11122093
[TBL] [Abstract][Full Text] [Related]
36. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
[TBL] [Abstract][Full Text] [Related]
37. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
[TBL] [Abstract][Full Text] [Related]
38. Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report.
Wada Y; Uchiba M; Kawano Y; Kai N; Takahashi W; Honda J; Tanoue K; Maeda Y; Murakami Y; Eto M; Imamura T
J Med Case Rep; 2012 Nov; 6():378. PubMed ID: 23130841
[TBL] [Abstract][Full Text] [Related]
39. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.
Nishiyama T; Yokoyama T; Yamashita K
J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236
[TBL] [Abstract][Full Text] [Related]
40. Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.
Saadah NH; van der Meer PF; Brinkman HJM; de Korte D; Bontekoe IJ; Korsten HH; Middelburg RA; van der Bom JG; Schipperus MR
Transfusion; 2017 Oct; 57(10):2381-2389. PubMed ID: 28727139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
